Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-16

Clinical Trial Update: Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the combination of olanzapine and amisulpride to monotherapy in schizophrenia and schizoaffective disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amisulpride (amisulpride)
  • olanzapine (olanzapine)

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED